Yahoo! Finance Search - Finance Home - Yahoo! - Help

Wednesday, November 19 2008 1:17am ET - U.S. Markets open in 8 hours and 13 minutes.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drugs - Generic News
View: Latest News | Top Stories
Tuesday, Nov 18, 2008
·Mylan: FDA OKs application for fluoxetine capsules
AP - Tue 8:52 am ET
·Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules
PR Newswire - Tue 8:00 am ET
Monday, Nov 17, 2008
·Mylan Receives Tentative FDA Approval for the Generic Version of the Antidepressant Effexor XR(R)
PR Newswire - Mon 8:00 am ET
Friday, Nov 14, 2008
·Attorneys move to close Actavis NJ facilities
AP - Fri Nov 14
·Helicos Launches Open Access Web Site With Microbial Genome Data
Business Wire - Fri Nov 14
·Catalyst Pharmaceutical Partners Reports Third Quarter 2008 Financial Results
PR Newswire - Fri Nov 14
·Pro-Pharmaceuticals to Commence Rights Offering to Shareholders
Business Wire - Fri Nov 14
Thursday, Nov 13, 2008
·FDA to review Watson's longer-lasting cancer drug
AP - Thu Nov 13
·Pro-Pharmaceuticals Receives Delisting Notice from NYSE Alternext US
Business Wire - Thu Nov 13
·Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
PR Newswire - Thu Nov 13
Friday, Nov 7, 2008
·Par Pharmaceutical Companies Inc. Q3 2008 Earnings Call Transcript
at Seeking Alpha - Fri Nov 7
·[external] Barr profit slides, but ex-items it beats estimates
at bizjournals.com - Fri Nov 7
·Pro-Pharmaceuticals Reports Third Quarter Results
Business Wire - Fri Nov 7
Thursday, Nov 6, 2008
·Barr Pharmaceuticals Inc. Q3 2008 Earnings Call Transcript
at Seeking Alpha - Thu Nov 6
·Par Pharmaceutical Reports Third Quarter 2008 Results
PR Newswire - Thu Nov 6
·Sector Snap: Generic drug cos. show strong profits
AP - Thu Nov 6
·Barr narrows 2008 profit and revenue outlooks
AP - Thu Nov 6
·Barr says costs push 3Q profit down 21 percent
AP - Thu Nov 6
·Mylan's Dey L.P. Announces Establishment of 'J-Code' for Perforomist(TM) Inhalation Solution
PR Newswire - Thu Nov 6
·Par Pharmaceutical Begins Shipment of Sumatriptan Injection
PR Newswire - Thu Nov 6
More Latest News...
Sponsor Results
Live Forex Practice Account
Practice Forex Trading in Real Market Conditions with a Free Trial.
www.GFTforex.com
Countrywide® Home Loans
No Cash Required For Closing Costs. Call Or Apply Online Now.
www.Countrywide.com
Free 3 in 1 Credit Report
Free 3-bureau Credit Report - includes Transunion, Equifax, Experian.
FreeCreditReportsInstantly.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo! Page
( About My Yahoo! and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds


Copyright © 2008 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2008 Morningstar, Inc. All Rights Reserved. Company information © 2008 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2008, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?